Sheldon Sloan

Sheldon Sloan

Chief Medical OfficeratSpyre Therapeutics· In proxies 2024–2025

Pay in FY2025-76% from the year before · Spyre Therapeutics stock +40.7% the same year

Sheldon Sloan was paid $2.2M in FY2025 (Dec), down 76%. Spyre Therapeutics stock rose 40.7% that year.

Pay$100 in the stock at the end of FY23 → $152
Pay is from the Summary Compensation Table of each Spyre Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Spyre TherapeuticsPublic company · 2 yr
    • Chief Medical Officer2024 – Present · 2 yrStock in role +417%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?